| Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity M Pešić, A Podolski-Renić, S Stojković, B Matović, D Zmejkoski, V Kojić, ... Chemico-biological interactions 232, 85-93, 2015 | 190 | 2015 |
| Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs M Pesic, JZ Markovic, D Jankovic, S Kanazir, ID Markovic, L Rakic, ... Journal of chemotherapy 18 (1), 66-73, 2006 | 126 | 2006 |
| Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles V Lopes-Rodrigues, A Di Luca, J Mleczko, P Meleady, M Henry, M Pesic, ... Scientific Reports 7, 44541, 2017 | 85 | 2017 |
| Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway Q Liu, D Manzano, N Tanić, M Pesic, J Bankovic, I Pateraki, L Ricard, ... Metabolic engineering 23, 145-153, 2014 | 83 | 2014 |
| The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines A Podolski-Renić, T Anđelković, J Banković, N Tanić, S Ruždijić, M Pešić Biomedicine & Pharmacotherapy 65 (5), 345-353, 2011 | 80 | 2011 |
| Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R) T Andjelkovic, M Pesic, J Bankovic, N Tanic, ID Markovic, S Ruzdijic Cancer biology & therapy 7 (7), 1024-1032, 2008 | 76 | 2008 |
| Isolation and biological evaluation of jatrophane diterpenoids from Euphorbia dendroides IS Aljančić, M Pešić, SM Milosavljević, NM Todorović, M Jadranin, ... Journal of natural products 74 (7), 1613-1620, 2011 | 74 | 2011 |
| Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma Z Milosevic, M Pesic, T Stankovic, J Dinic, Z Milovanovic, J Stojsic, ... Translational Research 164 (5), 411-423, 2014 | 73 | 2014 |
| What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg T Alexa-Stratulat, M Pešić, AČ Gašparović, IP Trougakos, C Riganti Drug Resistance Updates 46, 100643, 2019 | 68 | 2019 |
| Advanced technological tools to study multidrug resistance in cancer L Andrei, S Kasas, IO Garrido, T Stanković, MS Korsnes, R Vaclavikova, ... Drug Resistance Updates 48, 100658, 2020 | 66 | 2020 |
| Cytotoxic activity of sesquiterpene lactones from Inula britannica on human cancer cell lines JT Fischedick, M Pesic, A Podolski-Renic, J Bankovic, RCH de Vos, ... Phytochemistry Letters 6 (2), 246-252, 2013 | 58 | 2013 |
| Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines M Jadranin, M Pešić, IS Aljančić, SM Milosavljević, NM Todorović, ... Phytochemistry 86, 208-217, 2013 | 58 | 2013 |
| Dual inhibitors as a new challenge for cancer multidrug resistance treatment T Stanković, J Dinić, A Podolski-Renić, L Musso, SS Burić, S Dallavalle, ... Current medicinal chemistry 26 (33), 6074-6106, 2019 | 56 | 2019 |
| Development of natural product drugs in a sustainable manner M Pesic Brief for GSDR, 2015 | 55* | 2015 |
| New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer J Dinic, A Podolski-Renic, T Stankovic, J Bankovic, M Pesic Current Pharmaceutical Design 21 (38), 5589-5604, 2015 | 54 | 2015 |
| In vitro biomimetic models for glioblastoma-a promising tool for drug response studies T Stanković, T Ranđelović, M Dragoj, SS Burić, L Fernández, I Ochoa, ... Drug Resistance Updates 55, 100753, 2021 | 50 | 2021 |
| Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action V Neergheen-Bhujun, AT Awan, Y Baran, N Bunnefeld, K Chan, ... Journal of global health 7 (2), 2017 | 46 | 2017 |
| Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing A Podolski-Renić, M Jadranin, T Stanković, J Banković, S Stojković, ... Cancer chemotherapy and pharmacology 72 (3), 683-697, 2013 | 46 | 2013 |
| Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models C PR Xavier, M Pesic, M Helena Vasconcelos Current cancer drug targets 16 (3), 226-237, 2016 | 45 | 2016 |
| New anti-cancer characteristics of jatrophane diterpenes from< i> Euphorbia dendroides</i> M Pešić, J Banković, IS Aljančić, NM Todorović, M Jadranin, VE Vajs, ... Food and Chemical Toxicology, 2011 | 45 | 2011 |
Miodrag DragojResearch Associate, Institute for Biological Research "Sinisa Stankovic", University of BelgradeEmail verificata su ibiss.bg.ac.rs
